is mounjaro glp 1 Eli Lilly launches weight loss drug in India at Rs 3,500 per 2.5mg dose Mounjaro (tirzepatide) is a dual
Description
Since private labeling involves selling a standardized product that many other brands may also offer, it becomes challenging to differentiate your business in the market
It's not just about health problems
The effects of GLP-1 medications may not be permanent
You are not even trying to suppress appetite
These groundbreaking medications, initially approved for patients with type 2 diabetes, are now revolutionizing chronic disease treatment through their metabolic, hormonal, and anti-inflammatory effects, becoming vital tools in addressing conditions like cardiovascular disease, nonalcoholic fatty liver disease, osteoarthritis, and more
Asia Pacific Prescription Drug Market Size and Forecast by Segmentation (in USD Bn) 2025-2032 7.4.1
